Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes.

Cardiovasc Diabetol · 2021 · PMC7798345 · PMID 33430860

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

Patients with reduced kidney function achieved greater proportional risk reductions for MACE (23% reduction) than patients with preserved kidney function (9% reduction), although the difference was of borderline significance (P for heterogeneity between subgroups = 0.053) (Fig. 1 ) [ 33 ].

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.